TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12172954

Group type: EXPERIMENTAL
Intervention: Intra-articular high molecular weight hyaluronan injection after arthrocentesis
Number of subjects: 118

Group type: COMPARATOR
Intervention: No arthrocentesis before hyaluronan injection
Number of subjects: 118
Study: 10439751

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 5, 7.5, 10, 15, 20, or 25 micrograms
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl
Number of subjects: 90
Study: 7873109

Group type: EXPERIMENTAL
Intervention: Dance-based exercise program (12 weeks, twice weekly)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (10 participants, mean age 49.4 ± 12 years)
Number of subjects: 19
Study: 2240504

Group type: EXPERIMENTAL
Intervention: Buprenorphine 2.5 micrograms/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Buprenorphine 5.0 micrograms/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Prolonged infusions of propofol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Postoperative questioning
Number of subjects: 36
Study: 359081

Group type: EXPERIMENTAL
Intervention: Mianserin 20 mg three times daily plus placebo lithium tablets
Number of subjects: 41

Group type: COMPARATOR
Intervention: Lithium tablets once daily plus placebo mianserin tablets
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Mianserin 20 mg three times daily (increased to 30 mg t.d.s. after one year)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Lithium tablets once daily
Number of subjects: 41
Study: 29943177

Group type: EXPERIMENTAL
Intervention: Monarc® (outside-in trans-obturator technique)
Number of subjects: 120

Group type: COMPARATOR
Intervention: TVT-O® (inside-out trans-obturator technique)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 120
Study: 29916428

Group type: EXPERIMENTAL
Intervention: Prophylactic hydration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 25980552

Group type: EXPERIMENTAL
Intervention: Duloxetine (40-60 mg/day)
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1522
Study: 23859696

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: NRT plus bupropion
Number of subjects: 1071

Group type: COMPARATOR
Intervention: NRT
Number of subjects: 1071
Study: 21809362

Group type: EXPERIMENTAL
Intervention: BMS-790052 (1, 10, 30, 60, and 100 mg, once-daily or 30 mg twice-daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BMS-790052
Number of subjects: 24
Study: 19734380

Group type: EXPERIMENTAL
Intervention: Acupuncture (8 weekly sessions using four bilateral acupuncture points)
Number of subjects: 12
Study: 16455695

Group type: EXPERIMENTAL
Intervention: 20 mug oral misoprostol solution at hourly intervals
Number of subjects: 741

Group type: COMPARATOR
Intervention: Vaginal dinoprostone gel at six hourly intervals
Number of subjects: 741
Study: 12677735

Group type: EXPERIMENTAL
Intervention: Intra-nasal mometasone furoate (MF) 200 mg once daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 10933100

Group type: EXPERIMENTAL
Intervention: LPS (lipopolysaccharide)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GLU (beta‐1,3‐D‐glucan)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: LPS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GLU
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 10
Study: 8822346

Group type: EXPERIMENTAL
Intervention: Strength training (3 x 8 repetition maximum)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Endurance training (3 x 20 repetition maximum)
Number of subjects: 56
Study: 1579391

Group type: EXPERIMENTAL
Intervention: 800 micrograms of budesonide
Number of subjects: 43

Group type: COMPARATOR
Intervention: 200 micrograms of budesonide
Number of subjects: 43

Group type: COMPARATOR
Intervention: 400 micrograms of budesonide
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 3913177

Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 185

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 185
Study: 31613942

Group type: EXPERIMENTAL
Intervention: Feather-edge preparation (Group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chamfer preparation (Group 2)
Number of subjects: 50
Study: 30128724

Group type: EXPERIMENTAL
Intervention: Doula-Home-Visiting Services
Number of subjects: 0
Study: 26063452

Group type: COMPARATOR
Intervention: Fluoroscopy-guided targeted continuous cervical epidural block (FCCEB)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous interscalene brachial plexus block (UCISB75)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous interscalene brachial plexus block (UCISB20)
Number of subjects: 75
Study: 25509262

Group type: EXPERIMENTAL
Intervention: Xuebijing Injection (50 mL XI in 100 mL normal saline, injected twice daily for 3 days post-THA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (routine perioperative therapies only)
Number of subjects: 80
Study: 22734945

Group type: EXPERIMENTAL
Intervention: Intervention schools (n=4)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Control schools (n=4)
Number of subjects: 579
Study: 20333473

Group type: EXPERIMENTAL
Intervention: ECMO therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-term, large-scale observational study
Number of subjects: 0
Study: 17697016

Group type: EXPERIMENTAL
Intervention: peginterferon (peg-IFN) alpha 2b plus ribavirin
Number of subjects: 416

Group type: COMPARATOR
Intervention: interferon alpha-2b plus ribavirin
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: zidovudine
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: peg-IFN
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: higher baseline haemoglobin levels
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: protease inhibitor-based antiretroviral therapy
Number of subjects: 416
Study: 16259547

Group type: EXPERIMENTAL
Intervention: Risperidone at flexible doses of 0.5 to 1.5 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12080281

Group type: EXPERIMENTAL
Intervention: Pyridoxine (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10378497

Group type: COMPARATOR
Intervention: Moderate-Intensity Exercise Group (MIG)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise Group (HIG)
Number of subjects: 25
Study: 8679761

Group type: EXPERIMENTAL
Intervention: Fundoplication with total fundal mobilisation (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional Nissen‐Rossetti procedure (n = 10)
Number of subjects: 20
Study: 1829401

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6365468

Group type: EXPERIMENTAL
Intervention: 200 mg fentiazac twice daily for 6 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: 50 mg indomethacin twice daily for 6 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 200 mg fentiazac twice daily for 2 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: 200 mg phenylbutazone twice daily for 2 weeks
Number of subjects: 44
Study: 30006778

Group type: EXPERIMENTAL
Intervention: Low supplementation (LOHI; 0.2% of BW/heifer/day) for first 90 days, high supplementation (0.6% of BW/heifer/day) for next 90 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Average supplementation (AVER; 0.4% of BW/heifer/day for 180 days)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High supplementation (HILO; 0.6% of BW/heifer/day for first 90 days, low supplementation (0.2% of BW/heifer/day) for next 90 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Only mineral mix (MM) ad libitum during 180 days
Number of subjects: 48
Study: 28835229

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (placebo)
Number of subjects: 0
Study: 26717405

Group type: EXPERIMENTAL
Intervention: OraQuick Rapid HIV‐1/2 antibody test
Number of subjects: 3678

Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 3678

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3678

Group type: EXPERIMENTAL
Intervention: HIV CRF01_AE
Number of subjects: 3678
Study: 23627281

Group type: EXPERIMENTAL
Intervention: Working memory dual-task during acquisition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Working memory dual-task at test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dual-task conditions in Experiment 2
Number of subjects: 0
Study: 21383650

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) treatment
Number of subjects: 171
Study: 18488812

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg delayed-released tablet (test formulation) without food
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg delayed-released tablet (test formulation) with food
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference pantoprazole 40 mg delayed-released tablet
Number of subjects: 0
Study: 16585381

Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham manipulative treatment
Number of subjects: 32
Study: 15603634

Group type: EXPERIMENTAL
Intervention: Videoconferencing (intervention group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Audioconferencing (control group)
Number of subjects: 100
Study: 10699344

Group type: EXPERIMENTAL
Intervention: Biojector(R) jet-injection system
Number of subjects: 1440

Group type: COMPARATOR
Intervention: Needle injection method
Number of subjects: 1440
Study: 9491679

Group type: EXPERIMENTAL
Intervention: Haemagglutination test using sensitized sheep red blood cells
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Haemagglutination inhibition test for detection of LPS antigen of S. typhi
Number of subjects: 530

Group type: COMPARATOR
Intervention: Haemagglutination test
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Haemagglutination inhibition test
Number of subjects: 530
Study: 8466095

Group type: EXPERIMENTAL
Intervention: Bricanyl Turbuhaler (BTH)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Ventolin metered-dose inhaler (VMDI)
Number of subjects: 159
Study: 3780329

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.5 mg bid)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3281449

Group type: EXPERIMENTAL
Intervention: Ferric polymaltose at a dose of 100 mg elemental iron twice daily for 56 days (group 1a)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo tablet administered on the same schedule (group 1b)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ferric polymaltose at a dose of 100 mg elemental iron twice daily for 56 days (group 2a)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo tablet administered on the same schedule (group 2b)
Number of subjects: 46
Study: 29454711

Group type: EXPERIMENTAL
Intervention: Tumescent technique
Number of subjects: 160

Group type: COMPARATOR
Intervention: Tourniquet
Number of subjects: 160
Study: 25782762

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for antepartum depression (IPT-P)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Parenting education program (PEP)
Number of subjects: 142
Study: 23582165

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Minocycline
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Probiotic and minocycline
Number of subjects: 45
Study: 21114777

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiation with 5‐fluorouracil/cisplatin (FP) followed by radiation (4500 cGY) and additional cycles of FP (arm A)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Chemotherapy with 5‐fluorouracil/cisplatin (FP) (arm B)
Number of subjects: 61
Study: 18208835

Group type: COMPARATOR
Intervention: Diuretics alone
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Diuretics plus irbesartan
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Diuretics plus ramipril
Number of subjects: 150
Study: 17010798

Group type: EXPERIMENTAL
Intervention: Famotidine (20 to 40 mg)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Famotidine (30 mg/day for 6 months)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Teprenone
Number of subjects: 209
Study: 14685865

Group type: EXPERIMENTAL
Intervention: Exercise in the heat at an ambient temperature of 35 degrees C (H)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Exercise in the cool at 15 degrees C (C)
Number of subjects: 7
Study: 11767419

Group type: COMPARATOR
Intervention: Positive control (similar to the supplement in the pilot study)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Polar olive oil phenols
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (without phenols)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non-polar olive oil phenols
Number of subjects: 12
Study: 9043728

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.0 to 1.5% (end-tidal) with nitrous oxide 66% in oxygen; anaesthesia induced with 5 mg.kg-1 thiopentone.
Number of subjects: 24
Study: 8330464

Group type: EXPERIMENTAL
Intervention: 1.0 mg alprazolam daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.5 mg alprazolam daily
Number of subjects: 12
Study: 3487646

Group type: EXPERIMENTAL
Intervention: D-penicillamine (DP) 500 mg daily
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: D-penicillamine (DP) 125 mg daily
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 30284878

Group type: EXPERIMENTAL
Intervention: Intensive Repeated Mailings (IRM)
Number of subjects: 1874

Group type: EXPERIMENTAL
Intervention: Standard Repeated Mailings (SRM)
Number of subjects: 1874

Group type: COMPARATOR
Intervention: Traditional Self‐Help (TSH)
Number of subjects: 1874
Study: 27776251

Group type: EXPERIMENTAL
Intervention: Exenatide BID
Number of subjects: 114

Group type: COMPARATOR
Intervention: Insulin lispro
Number of subjects: 114
Study: 24495519

Group type: EXPERIMENTAL
Intervention: Basic communication skills training (BCST) for nurses
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Augmentative and alternative communication devices and speech language pathologist consultation (AAC + SLP)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 89
Study: 22342792

Group type: EXPERIMENTAL
Intervention: Nail pick during surgical scrub
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Brush during surgical scrub
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgical scrub alone (control group)
Number of subjects: 60
Study: 20590963

Group type: COMPARATOR
Intervention: Coronally advanced flap (CAF) with connective tissue graft (CTG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Coronally advanced flap (CAF) with de-epithelialized gingival graft (DGG)
Number of subjects: 50
Study: 18325725

Group type: EXPERIMENTAL
Intervention: IL-2 (12 million UI/day for 3 days before operation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 15988076

Group type: EXPERIMENTAL
Intervention: Amoxicillin (40-45 mg/kg/24 h) + Sinupret (mucoregulatory remedy)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Amoxicillin (40-45 mg/kg/24 h)
Number of subjects: 64
Study: 12848587

Group type: EXPERIMENTAL
Intervention: ALX 111 (parathyroid hormone (1-84), rhPTH (1-84))
Number of subjects: 2600
Study: 11045408

Group type: EXPERIMENTAL
Intervention: 200-J monophasic shock
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 200-J biphasic shock
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 130-J biphasic shock
Number of subjects: 154
Study: 9483953

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation combined with inspiratory muscle training (IMT), n = 7
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional pulmonary rehabilitation only, n = 6
Number of subjects: 13
Study: 8508724

Group type: EXPERIMENTAL
Intervention: Behavioral treatment
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard drug counselling
Number of subjects: 59
Study: 3518966

Group type: EXPERIMENTAL
Intervention: Norfloxacin (NOR) 400 mg bid for 7 days
Number of subjects: 65

Group type: COMPARATOR
Intervention: Pipemidic acid (PA) 400 mg bid for 7 days
Number of subjects: 65
Study: 29939900

Group type: EXPERIMENTAL
Intervention: HIIT (10 × 60 seconds at 90% peak oxygen uptake [V̇o2peak], 1: 1 work to recovery at 50 W)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CETFAT (continuous endurance training at an intensity equivalent to maximal fat oxidation)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CETAT (continuous endurance training at an intensity equivalent to anaerobic threshold)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: HIIT and CETAT
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: HIIT and CETFAT
Number of subjects: 32

Group type: COMPARATOR
Intervention: CETAT
Number of subjects: 32

Group type: COMPARATOR
Intervention: CETFAT
Number of subjects: 32
Study: 31313142

Group type: EXPERIMENTAL
Intervention: Pharyngeal Electric Stimulation (PES)
Number of subjects: 15
Study: 31221870

Group type: EXPERIMENTAL
Intervention: Text messaging support (4 messages per week for 6 months)
Number of subjects: 1000
Study: 28625650

Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: S-1 + Bevacizumab (Bev)
Number of subjects: 78
Study: 26130070

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg, single intravenous infusion)
Number of subjects: 100
Study: 23937063

Group type: EXPERIMENTAL
Intervention: Interactive online curriculum
Number of subjects: 121

Group type: COMPARATOR
Intervention: Written curriculum
Number of subjects: 121
Study: 21675445

Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dry dressing
Number of subjects: 30
Study: 19324979

Group type: EXPERIMENTAL
Intervention: Exercise interventions
Number of subjects: 11
Study: 16893458

Group type: EXPERIMENTAL
Intervention: Email over 10 weeks
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Email within one week
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Website over 10 weeks
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Website within one week
Number of subjects: 780
Study: 15264777

Group type: EXPERIMENTAL
Intervention: Oxiplex/SP Gel (1-3 ml) applied at the conclusion of surgery
Number of subjects: 18

Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 18
Study: 11424467

Group type: EXPERIMENTAL
Intervention: Isoflurane/epidural anesthesia at 2.0 MAC
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isoflurane/epidural anesthesia at 1.2 MAC
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sevoflurane/epidural anesthesia at 2.0 MAC
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sevoflurane/epidural anesthesia at 1.2 MAC
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison of BIS at 2.0 MAC between isoflurane and sevoflurane
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison of BIS at 1.2 MAC between isoflurane and sevoflurane
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison of SEF 95 at 2.0 MAC between isoflurane and sevoflurane
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison of SEF 95 at 1.2 MAC between isoflurane and sevoflurane
Number of subjects: 17
Study: 9694026

Group type: EXPERIMENTAL
Intervention: Flumazenil (1 mg i.v.)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 34
Study: 7944469

Group type: EXPERIMENTAL
Intervention: Intraperitoneal treatment with MMC‐CH
Number of subjects: 113

Group type: COMPARATOR
Intervention: No anti‐cancer drugs (Control)
Number of subjects: 113
Study: 3364181

Group type: EXPERIMENTAL
Intervention: Prophylactic anticoagulation starting 4 days before the operation
Number of subjects: 101

Group type: COMPARATOR
Intervention: Prophylactic anticoagulation starting on the eve of the operation
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Postoperative anticoagulation set at an INR of 2.1
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Postoperative anticoagulation
Number of subjects: 101
Study: 31665279

Group type: EXPERIMENTAL
Intervention: Vacuum‐formed Essix C‐retainers (VFR)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Bonded cuspid‐to‐cuspid retainers (CTC)
Number of subjects: 104
Study: 29135036

Group type: EXPERIMENTAL
Intervention: Dual wavelength picosecond Nd:YAG laser (532 nm and 1,064 nm)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Picosecond 755 nm alexandrite laser
Number of subjects: 29
Study: 28629489

Group type: EXPERIMENTAL
Intervention: Eating less during late pregnancy
Number of subjects: 4011
Study: 24720375

Group type: EXPERIMENTAL
Intervention: Vascularized interpositional periosteal‐connective tissue graft (test)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Free subepithelial connective tissue graft (control)
Number of subjects: 20
Study: 23792412

Group type: EXPERIMENTAL
Intervention: MTO intervention
Number of subjects: 2829

Group type: EXPERIMENTAL
Intervention: Post-move services
Number of subjects: 2829
Study: 21398619

Group type: EXPERIMENTAL
Intervention: Lumpectomy followed by radiotherapy (LRT)
Number of subjects: 2612

Group type: EXPERIMENTAL
Intervention: LRT + Tamoxifen (LRT + TAM)
Number of subjects: 2612

Group type: COMPARATOR
Intervention: Lumpectomy only (LO)
Number of subjects: 2612

Group type: COMPARATOR
Intervention: LRT
Number of subjects: 2612

Group type: COMPARATOR
Intervention: LRT + placebo
Number of subjects: 2612

Group type: EXPERIMENTAL
Intervention: I‐IBTR
Number of subjects: 2612

Group type: COMPARATOR
Intervention: All patients (with or without I‐IBTR)
Number of subjects: 2612